Integrated micro-ceramic chemical plant with insertable catalytic
reaction chambers
    71.
    发明授权
    Integrated micro-ceramic chemical plant with insertable catalytic reaction chambers 失效
    具有可插入催化反应室的集成微陶瓷化工厂

    公开(公告)号:US5976472A

    公开(公告)日:1999-11-02

    申请号:US951180

    申请日:1997-10-15

    Abstract: An integrated micro-ceramic chemical plant having a unitary ceramic body formed from multiple ceramic layers in the "green" state which are sintered together including the unitary ceramic body defining a catalytic reaction chamber position and a first and second passages for providing communication with the catalytic reaction chamber position so that two or more fluids may be delivered to such reaction chamber position for reaction. The integrated micro-ceramic chemical plant further includes a unitary ceramic body defining a receiving chamber which includes the catalytic reaction chamber position, a movable member insertable into the receiving chamber and defining a plurality of catalytic reaction chambers. The movable member moves to the catalytic reaction chamber position where one of the catalytic reaction chambers is in communication with the first and second passages to cause the catalytic reaction of the fluids to produce reaction products.

    Abstract translation: 一种整体式微陶瓷化工厂,其具有由“绿色”状态的多个陶瓷层形成的单一陶瓷体,其被烧结在一起,包括限定催化反应室位置的整体陶瓷体和用于与催化剂连通的第一和第二通道 反应室位置,使得两个或更多个流体可以被输送到这样的反应室位置进行反应。 集成的微陶瓷化学设备还包括一体的陶瓷体,其限定包括催化反应室位置的接收室,可插入接收室并限定多个催化反应室的活动件。 可动件移动到催化反应室位置,其中一个催化反应室与第一和第二通道连通,引起流体的催化反应产生反应产物。

    Dose Synthesis Card for Use with Automated Biomarker Production System
    73.
    发明申请
    Dose Synthesis Card for Use with Automated Biomarker Production System 审中-公开
    用于自动生物标记生产系统的剂量合成卡

    公开(公告)号:US20150157743A1

    公开(公告)日:2015-06-11

    申请号:US14618732

    申请日:2015-02-10

    Abstract: Microfluidic radiopharmaceutical production system and process for synthesizing per run approximately, but not less than, ten (10) unit doses of radiopharmaceutical biomarker for use in positron emission tomography (PET). A radioisotope from an accelerator or other radioisotope generator is introduced into a reaction vessel, along with organic and aqueous reagents, and the mixture heated to synthesize a solution of a pre-selected radiopharmaceutical. The solution is purified by passing through a combination of solid phase extraction purification components, trap and release components, and a filter. The synthesis process reduces waste and allows for production of biomarker radiopharmaceuticals on site and close to the location where the unit dose will be administered to the patient. On-site, as-needed production of radiopharmaceuticals in small doses reduces the time between synthesis of the radiopharmaceutical and administration of that radiopharmaceutical, minimizing loss of active isotopes through decay and allowing production of lesser amounts of radioisotopes overall.

    Abstract translation: 微流体放射性药物生产系统和用于合成正电子发射断层扫描(PET)的大约但不小于十(10)个单位剂量的放射性药物生物标志物的方法。 来自加速器或其他放射性同位素发生器的放射性同位素与有机和含水试剂一起引入反应容器中,并将混合物加热以合成预先选定的放射性药物的溶液。 通过通过固相萃取纯化组分,捕集和释放组分和过滤器的组合来纯化溶液。 合成方法减少了废物,并允许在现场生产标记放射性药物并且靠近给予患者的单位剂量的位置。 在现场,按需要的小剂量放射性药物的生产减少放射性药物的合成和该放射性药物的给药之间的时间,通过衰减最小化活性同位素的损失,并允许总体产生较少量的放射性同位素。

Patent Agency Ranking